Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Endocrine 1

Conditions

Gliosarcoma 7Glioblastoma 6Sarcoma 5Brain Neoplasms 5Astrocytoma 5Oligodendroglioma 4Neuroblastoma 3Glioma 3Wilms Tumor 2Recurrence 2Neoplasm Metastasis 2Medulloblastoma 2Lymphoma, Large B-Cell, Diffuse 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Meningioma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leiomyosarcoma 1Hepatoblastoma 1Familial ependymoma 1

Interventions

tazemetostat 6X-Rays 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Cyclophosphamide 6Specimen Handling 5Etoposide 5Carboplatin 5etoposide phosphate 4Temozolomide 4Nuclear Medicine Department, Hospital 4Granulocyte Colony-Stimulating Factor 4palbociclib 3Topotecan 3Thiotepa 3Sirolimus 3Mesna 3Melphalan 3Ifosfamide 3Filgrastim 3Busulfan 3Biopsy 3ulixertinib 2tipifarnib 2selpercatinib 2omburtamab I-131 2olaparib 2larotrectinib 2ivosidenib 2fludarabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdoid Tumor × Vorinostat × Sarcoma × Clear all
NCT00217412 2014-06-17

Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia

National Cancer Institute (NCI)

Phase 1 Completed
60 enrolled
CNSLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Medulloblastoma, Neuroblastoma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡